. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Identification of the PKHDL1 Gene. A Receptor with Inducible T Lymphocyte Expression

Reference #:

2002-244

Inventors/Contributors

Peter C. Harris Ph.D., Marie C. Hogan M.D., Christopher J. Ward

Description

Mayo Clinic has discovered a gene, PKHDL1, that shows significant homology to PKHD1 (the gene mutated in autosomal recessive polycystic kidney disease that was discovered at Mayo and for which a patent application is pending). The protein predicted to be encoded by PKHDL1, fibrocystin-L, is a large receptor-like protein that is highly expressed on T lymphocytes. The protein is postulated to be an important receptor with a role in T-cell proliferation, cytokine production, migration patterns, cytotoxicity and/or cell survival and is highly expressed on specific cancerous cells.

Patent Status

Pending

Contact

Leif R. Nelson, Licensing Manager
nelson.leif@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 266-0820
Fax: (507) 284-5410